In accordance with TGC § 2177.008, the Texas Pharmaceutical Initiative Advisory Council (TPIAC) was established to advise the board on implementing TPI and carrying out the duties imposed on the board.
- The TPIAC is composed of:
- The executive commissioner of HHSC or the executive commissioner’s designee;
- The executive director of the Employees Retirement System of Texas or the executive director’s designee;
- The executive director of the Teacher Retirement System of Texas or the executive director’s designee;
- The chancellor of The University of Texas System or the chancellor’s designee; and
- The chancellor of The Texas A&M University System or the chancellor’s designee.
- Advisory Council Operations and Meetings
- The board may ask members of the TPIAC to attend board meetings to provide information related to the agency they represent and give advice on implementing TPI.
- The TPIAC is subject to the Open Meetings Act (OMA), as if it were a governmental body.
- The presence of a quorum of the TPIAC:
- Constitutes a TPIAC meeting that requires posting appropriate notice of the meeting as a full meeting of the TPIAC in accordance with the OMA; and
- Requires the TPIAC meeting to be held in compliance with the OMA, including posting appropriate notice of the meeting and keeping a recording or meeting minutes.
Advisory Council Members
- Michael Lopez, Deputy Executive Commissioner, Operations, Medicaid and CHIP Services Division, Texas Health & Human Services
- Blaise Duran, Director, Group Benefits Program, Employees Retirement System of Texas
- Katrina Daniel, Chief Health Care Officer, Teacher Retirement System of Texas
- Laura Chambers, Executive Director, Office of Employee Benefits, The University of Texas System
- Sheri Meyer, Director, System Benefits Administration, Texas A&M University System
Click HERE to download the full report.